For patients requiring dental procedures, there are no data available to suggest whether discontinuation of bisphosphonate treatment reduces the risk of osteonecrosis of the jaw.
Hambaravi protseduure vajavate patsientide osas puuduvad olemasolevad andmed, mis viitaksid sellele, kas bisfosfonaatravi katkestamine vähendab lõualuu osteonekroosi riski.